**THIS      PATENT LICENSE AND SALES EXCLUSIVITY AGREEMENT is made on November 9,      2005**

**1.**
**Summary**

| 1.1 | AVC                is a company incorporated in Taiwan. It has the expertise and                infrastructure required for the manufacture of cooling devices and                the                incorporation of such devices into PC applications. The said “PC”                hereunder means desktops, laptops and                notebooks. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.2 | iCurie                is a company incorporated in the United Kingdom and its Korean subsidiary                has developed and patented a technology relating to a new microfluidic                cooling system (“MCS”). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.3 | iCurie                Lab, Inc., the Korean subsidiary of iCurie, as described in sub-section                1.2, is a corporation incorporated under the laws of Republic of                Korea                (“Korea”) and having its principal place of business at 3F Joyang Bldg,                23-1, Seokchon Dong Songpa Gu, Seoul,                Korea. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.4 | AVC                and iCurie Lab, Inc. entered into a Collaboration Agreement                dated December                11, 2002 for the development of a cooling device using MCS technology,                and                agreed to certain terms and conditions in connection with the business                relationship, including but not limited to “Manufacturing” (section 3),                “Supply and Purchase Products” (section 4), “Distribution and Sales Right”                (section 5), “Intellectual Property Rights” (section 6) and “Use of                Technologies” (section 7). This Agreement replaces the Collaboration                Agreement in its entirety and the Collaboration Agreement is hereby                made                null, void and of no further                effect. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.5 | AVC                and iCurie signed a Letter of Intent dated on                April 28, 2005,                procuring                a further agreement about the development of cooling device using                MCS                technology. This Agreement replaces the Letter of Intent in its entirety                and the Letter of Intent is by made null, void and of no further                effect. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.6 | AVC                and iCurie have agreed to enter into this patent license and sales                exclusivity agreement in furtherance of the “Collaboration Agreement”                (mentioned as in sub-section 1.4) and “Letter of Intent” (mentioned as in                sub-section 1.5) to create a stand alone metal cooling device using                the                MCS technology for use in PCs (the “MCS Part”). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.7 | iCurie                will grant AVC (i) a worldwide, perpetual, non-revocable license                to use,                manufacture, have manufactured and import the MCS Part and to incorporate                the MCS Part into AVC cooling devices for PCs (the combination of                which                shall be called the “AVC Part”); and (ii) an exclusive right to sell and                offer for sale the MCS Part and the AVC Part only to PC manufacturers                headquartered anywhere in the world, except Korea and Japan. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.8 | AVC                will grant iCurie (i) a royalty for each MCS Part or AVC Part sold                by AVC;                (ii) the right to purchase the MCS Part and the AVC Part from AVC;                and                (ii) an exclusive right to sell the MCS Part and the AVC Part to                PC                manufacturers only headquartered in Korea and Japan.  |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.9 | AVC                and iCurie anticipate that the MCS Part and the AVC Part will be                ready for                sale by December 31, 2005. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

| **2.** | **Patent                License****Gran****t** |
|--------|------------------------------------------------|

| 2.1 | iCurie                grants to AVC, and AVC accepts, subject to the terms of this agreement,                a                worldwide, perpetual, non-revocable license to use any and all existent                intellectual property related to the patents listed on Schedule A                (the                “Patents”), solely for the purpose of manufacturing, having manufactured,                using, importing, supplying, offering to supply, selling and similar                disposing of the MCS Parts for use in PCs only. AVC may not grant                sub-licences under this license. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.2 | Any                and all improvement to the Patents, whether or not patented or patentable,                which is created or developed by iCurie or iCurie’s subsidiary after the                date of this Agreement shall be disclosed to AVC, and iCurie grants                AVC                hereby a license for such improvement under the terms of this                agreement. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **3.** | **Sales                Exclusivity** |
|--------|--------------------------------------|

| 3.1 | iCurie                hereby grants to AVC an exclusive right to sell and offer for sale                the MCS                Part and the AVC Part only to PC manufacturers headquartered anywhere                in                the world, except Korea and Japan. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 3.2 | AVC                hereby grants to iCurie (i) the right to purchase the MCS Part and                the AVC                Part from AVC for a markup of 15% above AVC’s manufacturing costs; and                (ii) an exclusive right to sell the MCS Part and the AVC Part to                PC                manufacturers headquartered in Korea and                Japan. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.3 | iCurie                shall have the exclusive right for (i) sales of the MCS Part or the                AVC                Part to third parties other than PC manufacturers; and (ii) sales                of                non-metal cooling devices using MCS                technology. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.4 | Without                prior written consent of iCurie, AVC shall not sell the MCS Part                or AVC                Part to PC manufacturers headquartered in Korea or Japan. Equally,                without                prior written consent of AVC, iCurie shall not sell the MCS Part                or AVC                Part to PC manufacturers other than headquartered in Korea or                Japan. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **4.** | **Royalty** |
|--------|-------------|

| 4.1 | In                consideration of the rights and exclusivities granted to AVC by iCurie                under this Agreement, AVC shall, within 30 days of the end of each                month                during the term of this Agreement, pay to iCurie royalties per                MCS Part or AVC Part sold by AVC during the term of this Agreement,                except                MCS Part or AVC Part supplied to iCurie, whether directly or indirectly.                The royalties are payable as outlined below: |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Yearly Volumes        | Royalties per MCS Part                                   |
|--------|-----------------------|----------------------------------------------------------|
|   |                  |                                                     |
|   | 1 - 2,000,000         | 10 % of AVC’s              average sale price      |
|   | 2,000,001 - 4,000,000 | 9% of AVC’s              average sale price   |
|   | 4,000,001 - 6,000,000 | 8 % of AVC’s              average sale price  |
|   | 6,000,001 - 8,000,000 | 7 % of AVC’s              average sale price       |
|   | 8,000,001 - or more   | 6 % of AVC’s              average sale price       |
|   |                  |                                                     |
|   |                  |                                                     |
|   | Yearly Volumes        | Royalties per AVC Part                                   |
|   |                  |                                                     |
|   | 1 - 2,500,000         | 7% of AVC’s              average sale price   |
|   | 2,500,001 - 5,250,000 | 6 % of AVC’s              average sale price       |
|   | 5,250,001 - 8,000,000 | 5 % of AVC’s              average sale price       |
|   | 8,000,001 - or more   | 4 % of AVC’s              average sale price       |

----

| **5.** | **Term                of Agreement** |
|--------|--------------------------------------|

| 5.1 | The                term of this Agreement (and the licenses and rights granted herein)                shall                be from the date this Agreement is executed through December 31,                2008;                provided however, iCurie shall have the right but not the obligation                to                terminate the sales exclusivity granted in Section 3.1 if AVC fails                to                sell the following volumes of MCS Parts and AVC Parts for the following                calendar years: |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Calendar Year | Number of MCS Parts and AVC Parts              Sold |
|--------|---------------|-----------------------------------------------------|
|   |          |                                                |
|   | 2006     | 3,000,000                                           |
|   | 2007     | 8,000,000                                      |
|   | 2008          | 19,000,000                                          |

| 5.2 | Upon                expiration or termination of this Agreement, all rights and obligations                hereunder shall terminate forthwith except the provisions of Sections                2                and 13. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **6.** | **Severability****.** |
|--------|-----------------------|

| 6.1 | If                any term or provision in this Agreement shall in whole or in part                be held                to any extent to be illegal or unenforceable by any court or other                competent authority that term or provision or part shall to that                extent be                deemed to be deleted and not form part of this agreement and the                enforceability of the remainder of this agreement shall not be affected.                In the event of any such deletion the parties shall negotiate in                good                faith in order to agree an alternative provision in place of the                provision                so deleted. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **7.** | **Modifications.** |
|--------|--------------------|

| 7.1 | Modifications                to this Agreement shall not be effective unless they are in writing                and                signed on behalf of all parties by an authorized                signatory. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **8.** | **Assigning                and Change of Control****.** |
|--------|---------------------------------------------------------|

| 8.1 | Neither                party may assign or otherwise deal in any of its rights under this                Agreement or sub-contract the performance of any of its obligations                under                this Agreement without the consent of the other                party. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.2 | If                ownership or management of either party is about to be subject to                a change                of control then such party shall give notice of the proposed change                of                control to the other party. In the event of a change of control of                the                ownership or management of a party, the other party may at any time                within                six months of such event coming to its attention terminate this agreement                immediately by giving notice to changed                party. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **9.** | **Relationship                between the Parties****.** |
|--------|----------------------------------------------------------|

| 9.1 | Nothing                in this Agreement creates a partnership, agency relationship, franchise,                employment relationship between the parties. No party is permitted                to                enter into any Agreement with a third party on behalf of any other,                nor                make any representation or give any warranty to a third party on                behalf of                any other to act as, or represent that it is an agent of any other                party,                or otherwise bind any other party in any manner whatsoever without                the                consent of that other. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **10.** | **Entire                Agreement****.** |
|---------|------------------------------------------|

| 10.1 | This                Agreement constitutes the entire agreement between the parties and                supersedes any previous agreement between the parties in relation                to the                subjects covered by them. Each party acknowledges and agrees that                it has                not been induced to enter into this Agreement in reliance upon any                representation, warranty or other term other than as expressly set                out in                this agreement. The only remedy available to a party for breach of                such                representation, warranty or term shall be for breach of contract.                Nothing                in this agreement shall limit or exclude liability for fraud or fraudulent                misrepresentation. Except as expressly set out in this agreement                all                conditions, warranties, representations and other terms, whether                express                or implied by statute, common law, trade practice or howsoever, are                excluded. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **11.** | **Notices****.** |
|---------|------------------|

| 11.1 | All                notices and consents relating to this Agreement must be in writing                and                signed by an authorised signatory. Notices may be sent by                internationally-recognized courier to the addressee's address (or                such                other address as it may have notified to the party giving the notice)                and                any notice so sent shall be considered served on the date that it                would                have been received in the normal course of post. Notices may be sent                by                fax provided (a) an acknowledgment of receipt is received by the                sending                machine and (b) a copy of the notice is sent by internationally-recognized                courier the same or the following                day. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **12.** | **Waiver****.** |
|---------|-----------------|

| 12.1 | If                a party delays in enforcing its rights under this Agreement (whether                in                relation to a breach by the other party or otherwise) then unless                the                party concerned expressly agrees otherwise, that delay shall not                be                treated as waiving the rights of the party concerned. The single                or                partial exercise of any right, power or remedy shall not preclude                any                other or further exercise of that right, power or remedy. Any waiver                of a                party's rights in relation to a particular breach of this Agreement                shall                not operate as a waiver of any subsequent breach. No custom or practice                of                the parties at variance with the terms of this Agreement shall constitute                a waiver of the rights of either party under this                Agreement. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **13.** | **Indemnity** |
|---------|---------------|

| 13.1 | iCurie                shall at its expense, defend, indemnify and hold harmless AVC, its                subsidiaries, its subcontractors and its customers and any of their                officers, directors, employees or agents, from and against any and                all                damages, claims, losses and/or expenses, including, without limitation,                reasonable attorney’s fees, arising out of, in connection with or relating                to any and all action or claim that the MCS Part infringe or                misappropriate any patent, copyright, trade secret, trademark or                other                intellectual property rights of any third party; provided that AVC                shall                (i) notify iCurie in writing of the action or claim, (ii) provide                iCurie                with reasonable information and assistance at iCurie’s expense for the                defense or settlement of the action or claim, and (iii) grant iCurie                reasonable control of the defense or settlement of the action or                claim                through representatives reasonably acceptable to                AVC. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 13.2 | In                the event that the MCS Part (or AVC Part because of MCS Part) are                held to                infringe or misappropriate any patent, copyright, trade secret, trademark                or other intellectual property rights of any third party or their                use is                enjoined, an injunction issues as a result of any action or claim                iCurie                shall at its own expense, and AVC’s option to either (i) procure for AVC,                its subsidiaries, its subcontractors and its customers the royalty-free                right to continue distributing, using, manufacturing, importing,                selling                and offering for sale MCS Part and AVC Part; or (ii) refund to AVC                the                royalty paid for any MCS Part and AVC Part.   |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **14.** | **Cumulative                Remedies.** |
|---------|-----------------------------------------|

| 14.1 | Any                right, remedy or power to which either party is or may become entitled                under this Agreement or in consequence of another's conduct may be                enforced from time to time separately or concurrently with any right                or                remedy given by this Agreement or now or afterwards provided for                and                arising by operation of law so that such rights and remedies are                not                exclusive of the other or others but are                cumulative. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **15.** | **Rights                of Third Parties****.** |
|---------|-------------------------------------------------|

| 15.1 | No                term of this agreement shall be enforceable by a party other than                the                parties to this Agreement. The parties reserve the right to rescind                or                vary this Agreement without the consent of any person who is not                a party                to the Agreement. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **16.** | **Further                Assurance****.** |
|---------|-------------------------------------------|

| 16.1 | Each                party to this Agreement shall at the request and expense of the others                execute and do any deeds and things reasonably necessary to give                effect to                this Agreement. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **17.** | **Publicity****.** |
|---------|--------------------|

| 17.1 | No                party may include another's name or any information concerning the                transactions referred to in this Agreement in any of its publicity                material, press announcements or other communications without first                obtaining that other party's written consent, except that nothing                shall                restrict the parties from complying with any regulation or legislation                pertaining to public announcements. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **18.** | **Precedence****.** |
|---------|---------------------|

| 18.1 | In                the event of any conflict between the provisions of this Agreement                and the                provisions of any subsequent confirmatory or formal license the provisions                of this Agreement shall prevail. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **19.** | **Counterparts****.** |
|---------|-----------------------|

| 19.1 | This                Agreement may be executed in any number of counterparts, each of                which                shall be deemed to be an original, and which together shall constitute                one                and the same agreement. Unless otherwise provided in this agreement,                this                agreement shall become effective and be dated (and each counterpart                shall                be dated) on the date on which this Agreement (or a counterpart of                this                agreement) is signed by the last of the parties to execute this agreement                or, as the case may be, a counterpart                thereof. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **20.** | **Governing                law and dispute resolution****.** |
|---------|--------------------------------------------------------------|

| 20.1 | This                agreement is governed by and shall be construed in accordance with                the law                of the Republic of South Korea. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 20.2 | Any                disagreement, dispute, controversy or claim arising out of or relating                to                this Agreement or the interpretation hereof or any arrangements relating                hereto or contemplated herein or the breach, termination or invalidity                hereof shall be settled exclusively and finally by arbitration. It                is                specifically understood and agreed that any disagreement, dispute                or                controversy which cannot be resolved between the Parties, including                without limitation any matter relating to the interpretation of this                Agreement, shall be submitted to                arbitration. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 20.3 | The                arbitration shall be conducted pursuant to the Rules of Conciliation                and                Arbitration of the International Chamber of Commerce (the "ICC                Rules"). |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 20.4 | The                arbitration shall be (i) conducted in Seoul, Korea, if brought by                AVC, and                (ii) conducted in Taipei, Taiwan, if brought by                iCurie. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 20.5 | The                language used in the arbitration shall be the English                language. |
|------|---------------------------------------------------------------------------------------------------|

| 20.6 | Any                decision or award of the arbitral tribunal shall be final and binding                upon                the Parties to the arbitration proceeding. The Parties waive to the                extent                permitted by law any rights to appeal or to review of such award                by any                court or tribunal. The Parties hereto agree that the arbitral award                may be                enforced against the Parties to the arbitration proceeding or their                assets                wherever they may be found and that a judgment upon the arbitral                award may                be entered in any court having jurisdiction                thereof. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**ACCEPTED      AND AGREED:**

| “iCURIE”                    | “AVC”                      |   |
|-----------------------------------------|----------------------------------------|--------|
|                                    |                                   |   |
| iCurie Lab Holdings Limited             | Asia Vital Components, Inc.            |   |
|                                    |                                   |   |
| Signed: /s/              Hakan Wretsell | Signed: /s/              J.C. Lin |   |
|                                    |                                   |   |
| Name: Hakan              Wretsell       | Name: J.C.              Lin            |   |
|                                    |                                   |   |
| Title: CEO                              | Title: CTO                             |   |

----

**SCHEDULE      A**

**PATENTS      LICENSED FROM iCURIE TO AVC**

|  **Description**                                                                                            |  **Country** | **Patent****Registration/Application                Number**  |
|------------------------------------------------------------------------------------------------------------------|-------------------|---------------------------------------------------------------|
|  Micro                cooling device                                                                        |  Korea       |  Registration                Number:0294317              |
|  Planar                type heat transferring device and manufacturing method                thereof        |   Korea |   Application                Number:10-2004-0091617 |
|  Heat                transfer device and manufacturing method thereof using hydrophilic                wick |   Korea |   Application                Number:10-2005-0001028 |

----